Stanford Health Policy is a joint effort of the Freeman Spogli Institute for International Studies and the Stanford School of Medicine
Comparative effectiveness research
Scholarly Publications
Anesthesia Care Team Composition and Surgical Outcomes
August 2018
The adjusted mortality for care teams with anesthesiologist assistants was 1.6% (95% CI, 1.4 to 1.8) versus 1.7% for care teams with nurse anesthetists (95% CI, 1.7 to 1.7; difference −0.08; 95% CI...
Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum β-Lactamase–Producing Organisms, Hyderabad, India
August 2018
The decreasing effectiveness of antimicrobial agents is a global public health threat, yet risk factors for community-acquired antimicrobial resistance (CA-AMR) in low-income settings have not been...
ACA Marketplace Premiums and Competition Among Hospitals and Physician Practices
July 2018
In this study published in the American Journal of Managed Care, the authors found that premiums for ACA Marketplace plans were higher in rating areas in which physician, hospital, and insurance...
Other Publications
Evidence-Based Practice for Public Health Emergency Preparedness and Response
July 2020
Yet there has been no national-level, comprehensive review of the evidence for public health emergency preparedness and response (PHEPR) practices.
Comparative Effectiveness Research Prioritization
June 2009
Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options.
News
Examining the Value of Pharmacy Benefit Managers
March 2020
Most Americans don’t realize there are silent brokers helping to fix the price of their prescription drugs — or that it’s a $100 billion annual business accounting for half of Big Pharma sales.
Michelle Mello Answers Questions About the Federal Rollout of the Coronavirus Test
March 2020
We asked Stanford Health Policy's Michelle Mello — a professor of medicine and law — to answer some questions about the federal rollout of diagnostic testing for the coronavirus.
Task Force: Not Enough Evidence to Recommend Screening for Cognitive Impairment in Elderly
February 2020
More evidence-based research is needed before the U.S.
Old Events